Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical Potential of Hypoxia Inducible Factors Prolyl Hydroxylase Inhibitors in Treating Nonanemic Diseases
Mengqiu Miao, Mengqiu Wu, Yuting Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review
Michelangela Barbieri, Paolo Chiodini, Piergiacomo Di Gennaro, et al.
Pharmacological Research (2024) Vol. 203, pp. 107146-107146
Open Access | Times Cited: 14
Biochemistry of the hypoxia-inducible factor hydroxylases
Giorgia Fiorini, Christopher J. Schofield
Current Opinion in Chemical Biology (2024) Vol. 79, pp. 102428-102428
Open Access | Times Cited: 10
Efficacy and safety of roxadustat for treating anemia in patients with chronic kidney disease and heart failure: a retrospective cohort study
Jiang Liu, Meng Zhen, Lina Feng, et al.
Clinical Kidney Journal (2025) Vol. 18, Iss. 4
Open Access | Times Cited: 1
Metabolic reprogramming in septic acute kidney injury: pathogenesis and therapeutic implications
Caihong Liu, Wei Wei, Yongxiu Huang, et al.
Metabolism (2024) Vol. 158, pp. 155974-155974
Closed Access | Times Cited: 8
New Iron Metabolic Pathways and Chelation Targeting Strategies Affecting the Treatment of All Types and Stages of Cancer
George J. Kontoghiorghes
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13990-13990
Open Access | Times Cited: 25
Roxadustat: do we know all the answers?
Qiuyu Li, Qian-Wen Xiong, Xuefeng Yao, et al.
Biomolecules and Biomedicine (2023)
Open Access | Times Cited: 14
Deferiprone and Iron–Maltol: Forty Years since Their Discovery and Insights into Their Drug Design, Development, Clinical Use and Future Prospects
George J. Kontoghiorghes
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4970-4970
Open Access | Times Cited: 14
Managing Anemia: Point of Convergence for Heart Failure and Chronic Kidney Disease?
Oana Nicoleta Buliga-Finiș, Anca Ouatu, Daniela Maria Tănase, et al.
Life (2023) Vol. 13, Iss. 6, pp. 1311-1311
Open Access | Times Cited: 12
Adjuvant therapies for management of hemorrhagic shock: a narrative review
Yann Daniel, Frédérique Dufour‐Gaume, Amandine Vergnaud, et al.
Critical Care (2025) Vol. 29, Iss. 1
Open Access
Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology
George J. Kontoghiorghes
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6735-6735
Open Access | Times Cited: 13
Ischemic tubular injury: Oxygen-sensitive signals and metabolic reprogramming
Yalda Rahbar Saadat, Seyed Mahdi Hosseiniyan Khatibi, Anis Sani, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 4, pp. 1657-1669
Closed Access | Times Cited: 7
A Pharmacodynamic Evaluation of the Protective Effects of Roxadustat Against Hypoxic Injury at High Altitude
Qianwen Guo, Xue Li, Wenbin Li, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 75-85
Open Access | Times Cited: 6
Targeting HIF-1 for prostate cancer: a synthesis of preclinical evidence
Yarden Zohar, Nicola J. Mabjeesh
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 8, pp. 715-731
Closed Access | Times Cited: 6
Pharmacological HIF-1 activation upregulates extracellular vesicle production synergistically with adiponectin through transcriptional induction and protein stabilization of T-cadherin
Kohei Fujii, Yuya Fujishima, Shunbun Kita, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
PHD1-3 oxygen sensors in vivo—lessons learned from gene deletions
Agnieszka E. Jucht, Carsten C. Scholz
Pflügers Archiv - European Journal of Physiology (2024) Vol. 476, Iss. 9, pp. 1307-1337
Open Access | Times Cited: 1
The molecular and metabolic landscape of ferroptosis in respiratory diseases: Pharmacological aspects
Tong Wu, Miaorong Ji, Tian Li, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 15, Iss. 1, pp. 101050-101050
Open Access | Times Cited: 1
New Insights into Aspirin’s Anticancer Activity: The Predominant Role of Its Iron-Chelating Antioxidant Metabolites
George J. Kontoghiorghes
Antioxidants (2024) Vol. 14, Iss. 1, pp. 29-29
Open Access | Times Cited: 1
Comparative effectiveness and acceptability of HIF prolyl-hydroxylase inhibitors versus for anemia patients with chronic kidney disease undergoing dialysis: a systematic review and network meta-analysis
Qiong Huang, M. James You, Weijuan Huang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
The impact of obstructive sleep apnea on nonalcoholic fatty liver disease
Haiying Tang, Furong Lv, Peng Zhang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 3
Prolyl Hydroxylase Inhibition Mitigates Allograft Injury During Liver Transplantation
Jonathan M. Harnoss, Jun Cai, Sascha Hinterkopf, et al.
Transplantation (2022) Vol. 106, Iss. 10, pp. e430-e440
Open Access | Times Cited: 5
Risk of infection in roxadustat treatment for anemia in patients with chronic kidney disease: A systematic review with meta-analysis and trial sequential analysis
Shan Chong, Qiufen Xie, Tiantian Ma, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 3
Recent Advances and Therapeutic Implications of 2-Oxoglutarate-Dependent Dioxygenases in Ischemic Stroke
Jian Xie, Zhijun Zhang
Molecular Neurobiology (2023) Vol. 61, Iss. 7, pp. 3949-3975
Closed Access | Times Cited: 1
Renoprotective interventions efficacy in the late stages of CKD
D. S. Sadovskaya
IntechOpen eBooks (2024)
Open Access
Anti-SARS-CoV-2 Spike Antibody Response to the Fourth Dose of BNT162b2 mRNA COVID-19 Vaccine and Associated Factors in Japanese Hemodialysis Patients
Keiji Hirai, Masako Shimotashiro, Toshiaki Okumura, et al.
International Journal of Nephrology and Renovascular Disease (2024) Vol. Volume 17, pp. 135-149
Open Access
β3‐Adrenoceptor Agonism to Mimic the Biological Effects of Intrauterine Hypoxia: Taking Great Strides Toward a Pharmacological Artificial Placenta
Luca Filippi, Francesca Innocenti, Francesca Pascarella, et al.
Medicinal Research Reviews (2024)
Closed Access
Page 1 - Next Page

Scroll to top